Projected Income Statement: Scancell Holdings plc

Forecast Balance Sheet: Scancell Holdings plc

Forecast Balance Sheet - Scancell Holdings plc
Fiscal Period: April 2021 2022 2023 2024 2025 2026 2027
Net Debt 1 -25.9 -20.5 -19.2 -14.4 -16.8 10.4 15.8
Change - 20.85% 6.34% 25% -16.67% 162.01% 51.92%
Announcement Date 10/29/21 10/28/22 10/31/23 9/24/24 9/11/25 - -
1GBP in Million
Estimates

Cash Flow Forecast: Scancell Holdings plc

Fiscal Period: April 2021 2022 2023 2024 2025 2026 2027
CAPEX 1 0.744 1.268 0.203 - 0.014 0.013 0.013
Change - 70.43% -83.99% - - -7.14% 0%
Free Cash Flow (FCF) 1 - -11.46 -8.343 -15.84 -6.413 -11.53 -15.01
Change - - 27.21% -89.82% 59.51% -79.79% -30.16%
Announcement Date 10/29/21 10/28/22 10/31/23 9/24/24 9/11/25 - -
1GBP in Million
Estimates

Forecast Financial Ratios: Scancell Holdings plc

Fiscal Period: April 2020 2021 2022 2023 2024 2025 2026 2027

Profitability

        
EBITDA Margin (%) - - - -209.03% - -299.77% -1,159.45% -980.76%
EBIT Margin (%) - - - -226.14% - -318.42% -1,248.2% -1,000.95%
EBT Margin (%) - - - -271.37% - -324.84% -1,209.91% -1,034.13%
Net margin (%) - - - -226.45% - -260.5% -1,538.72% -1,210.62%
FCF margin (%) - - - -158.28% - -136.13% -922.37% -650.2%
FCF / Net Income (%) - - 555.01% 69.9% - 52.26% 59.94% 53.71%

Profitability

        
ROA -43.79% -21.06% -20.36% -21.66% -45.28% -40.18% - -
ROE -64.83% -114.08% -10.99% 1,676.4% 89.09% 334.39% - -

Financial Health

        
Leverage (Debt/EBITDA) - - - - - - -0.72x -0.7x
Debt / Free cash flow - - - - - - -0.9x -1.05x

Capital Intensity

        
CAPEX / Current Assets (%) - - - 3.85% - 0.3% 1.04% 0.56%
CAPEX / EBITDA (%) - -8.67% -10.1% -1.84% - -0.1% -0.09% -0.06%
CAPEX / FCF (%) - - -11.06% -2.43% - -0.22% -0.11% -0.09%

Items per share

        
Cash flow per share 1 - - - - - - - -
Change - - - - - - - -
Dividend per Share 1 - - - - - - - -
Change - - - - - - - -
Book Value Per Share 1 - - - - -0.00377 -0.0037 -0.0143 -
Change - - - - - 1.86% -286.49% -
EPS 1 - -0.0228 -0.0025 -0.015 -0.0068 -0.0126 -0.015 -0.0248
Change - - 89.04% -500% 54.67% -85.29% -18.73% -65.78%
Nbr of stocks (in thousands) - 815,219 815,219 818,403 928,980 1,027,258 1,212,231 1,212,231
Announcement Date - 10/29/21 10/28/22 10/31/23 9/24/24 9/11/25 - -
1GBP
Estimates
2026 *2027 *
P/E -6.28x -3.79x
PBR -6.57x -
EV / Sales 99.5x 56.2x
Yield - -

EPS & Dividend

EPS & Dividend - Scancell Holdings plc


Y-o-Y evolution of P/E

Valuation ratios - P/E - Scancell Holdings plc
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Scancell Holdings plc
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - Scancell Holdings plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.0940GBP
Average target price
0.2550GBP
Spread / Average Target
+171.28%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Scancell Holdings plc
  1. Stock Market
  2. Stocks
  3. SCLP Stock
  4. Financials Scancell Holdings plc